{"id":30485,"date":"2026-06-26T18:29:27","date_gmt":"2026-06-26T12:59:27","guid":{"rendered":"https:\/\/www.medicalbillersandcoders.com\/blog\/?p=30485"},"modified":"2026-06-26T19:03:53","modified_gmt":"2026-06-26T13:33:53","slug":"2026-medicare-rvu-cut-reducing-neurology-reimbursement","status":"publish","type":"post","link":"https:\/\/www.medicalbillersandcoders.com\/blog\/2026-medicare-rvu-cut-reducing-neurology-reimbursement\/","title":{"rendered":"How Are the 2026 Medicare RVU Adjustments Reducing Neurology Reimbursement?"},"content":{"rendered":"

The 2026 Medicare Physician Fee Schedule (MPFS) RVU adjustments are directly reducing per-encounter neurology reimbursement \u2014 with the budget-neutrality conversion factor cut translating to $8 to $22 in lost revenue per high-complexity office visit and compounding into $90,000 to $240,000 in per-physician annual shortfall for practices that have not restructured their Revenue Cycle Management (RCM)<\/strong> strategy in response.<\/p>\r\n

For neurology practices operating on Medicare-heavy patient panels, the 2026 MPFS is not a regulatory footnote \u2014 it is a margin compression mechanism that affects every billable encounter from a Level 4 E\/M visit to a nerve conduction study interpretation. Understanding exactly which CPT codes lost value, why the RVU reduction is structurally permanent, and what billing infrastructure changes can protect net realized revenue growth<\/strong> is the difference between a practice that stabilizes margins and one that absorbs the loss silently, quarter after quarter.<\/p>\r\n

For a foundational review of how RVU-based reimbursement affects neurology coding at the encounter level, see Understanding Basics of Neurology Billing for Improved Payments<\/a>.<\/p>\r\n

\r\n

What Are the 2026 Medicare RVU Adjustments \u2014 and Why Do They Hit Neurology Disproportionately?<\/h2>\r\n

The Medicare conversion factor \u2014 the dollar multiplier applied to every RVU assigned to a CPT code \u2014 was reduced in the 2026 MPFS final rule as part of the budget-neutrality requirement embedded in the Balanced Budget Act of 1997. When CMS increases RVU values for certain service categories (in 2026, primary care E\/M codes received targeted increases), the overall conversion factor must be adjusted downward to keep total Medicare spending neutral.<\/p>\r\n

For neurology, this creates a compounding loss: the specialty did not receive the proportional E\/M value increases allocated to primary care, yet it absorbs the same conversion factor reduction applied uniformly across all specialties. The result is a net reimbursement reduction on the highest-volume CPT codes in a neurology practice’s billing mix \u2014 precisely the codes that constitute the majority of Medicare revenue.<\/p>\r\n

The 2026 MPFS conversion factor<\/strong> decreased to approximately $32.35 per RVU from the prior year’s rate, representing a reduction that erodes reimbursement on every neurology encounter billed to Medicare and Medicare Advantage plans that use MPFS as their fee schedule basis.<\/p>\r\n

\r\n

How Much Is Your Neurology Practice Losing Per Physician?<\/h2>\r\n

The following model quantifies the 2026 MPFS impact for a neurology practice billing 400 to 600 Medicare encounters per month per physician \u2014 a volume consistent with a multi-condition neurologist managing an established Medicare patient panel:<\/p>\r\n

\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Revenue Category<\/th>\r\nMonthly Volume<\/th>\r\nPer-Encounter Loss<\/th>\r\nPer-12-Months Revenue Reduction<\/th>\r\n<\/tr>\r\n<\/thead>\r\n
High-complexity E\/M (99214\u201399215)<\/td>\r\n280\u2013380 encounters<\/td>\r\n$6\u2013$12<\/td>\r\n$20,160\u2013$54,720<\/td>\r\n<\/tr>\r\n
EEG interpretations (95812\u201395813)<\/td>\r\n30\u201360 studies<\/td>\r\n$7\u2013$11<\/td>\r\n$2,520\u2013$7,920<\/td>\r\n<\/tr>\r\n
Nerve conduction studies (95907\u201395913)<\/td>\r\n40\u201380 studies<\/td>\r\n$6\u2013$14<\/td>\r\n$2,880\u2013$13,440<\/td>\r\n<\/tr>\r\n
EMG studies (95860\u201395872)<\/td>\r\n20\u201340 studies<\/td>\r\n$4\u2013$6<\/td>\r\n$960\u2013$2,880<\/td>\r\n<\/tr>\r\n
CCM \/ Cognitive assessment codes<\/td>\r\n15\u201330 encounters<\/td>\r\n$3\u2013$8<\/td>\r\n$540\u2013$2,880<\/td>\r\n<\/tr>\r\n
Total per-physician impact<\/strong><\/td>\r\n\u00a0<\/td>\r\n\u00a0<\/td>\r\n$27,060\u2013$81,840<\/strong><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/div>\r\n

For a four-physician neurology group, the 2026 MPFS conversion factor reduction represents $108,240 to $327,360 in per-12-months revenue reduction<\/strong> \u2014 with no claim denials, no coding errors, and no operational failures involved. This is pure fee schedule compression.<\/p>\r\n

The practices absorbing this loss without a countermeasure are those relying on Medical Billing Services<\/strong><\/a> that benchmark performance against prior-year collections rather than current MPFS rates \u2014 and that do not have payer variance detection<\/strong> infrastructure identifying which Medicare Advantage plans have not yet adopted the 2026 MPFS conversion factor update in their own fee schedules.<\/p>\r\n

For a comprehensive review of how CPT and ICD-10 coding accuracy intersects with neurodiagnostic reimbursement, see Understanding CPT and ICD-10 Codes for Neurology Billing<\/a>.<\/p>\r\n

\r\n

The Medicare Advantage Divergence: Where Payer Variance Detection Becomes Critical<\/h2>\r\n

The 2026 MPFS conversion factor applies directly to traditional Medicare fee-for-service claims. Medicare Advantage (MA) plans, which now cover more than 50% of Medicare-eligible beneficiaries in most neurology practice markets, are not required to update their fee schedules on the same timeline. This creates a payer variance detection<\/strong> opportunity that most neurology practices are not systematically capturing.<\/p>\r\n

In the 60 to 180 days following a MPFS conversion factor adjustment, a measurable percentage of MA plans continue paying neurology claims at rates derived from the prior-year conversion factor \u2014 either because their internal fee schedule update cycle lags, because their contracts reference MPFS without specifying a calendar year update trigger, or because automated repricing engines have not yet loaded the current rate table.<\/p>\r\n

Practices with active payer variance monitoring identify these discrepancies and continue receiving the higher legacy rate through targeted claims tracking. Practices without this infrastructure simply receive whatever the MA plan’s system pays \u2014 and never know the difference.<\/p>\r\n

\r\n

Three Revenue Recovery Strategies That Offset the 2026 RVU Reduction<\/h2>\r\n

Strategy 1 \u2014 E\/M Level Optimization Through MDM-Based Documentation<\/h3>\r\n

The AMA’s 2021 E\/M revision shifted the basis for E\/M level selection from time-plus-examination to Medical Decision Making (MDM) complexity. For neurology, this revision created a systematic opportunity to bill Level 5 (99215) for encounters that, under the prior exam-based framework, were frequently coded at Level 4 (99214) due to documentation structure rather than clinical complexity.<\/p>\r\n

The neurology encounter that addresses epilepsy with medication adjustment, evaluates a new cognitive complaint, reviews a recent MRI, and manages co-existing hypertension meets the high-complexity MDM threshold for 99215 \u2014 provided the documentation captures the number and complexity of problems, the amount and complexity of data reviewed, and the risk of complications. Practices with MDM-aligned documentation protocols capture an additional $18 to $28 per encounter<\/strong> on visits that would otherwise default to 99214, generating $36,000 to $100,800 per physician in per-12-months revenue recovery that partially offsets the conversion factor reduction.<\/p>\r\n

Strategy 2 \u2014 Electrodiagnostic Add-On Code Capture<\/h3>\r\n

The most consistent source of Revenue Integrity<\/strong> loss in neurology electrodiagnostic billing is not the primary NCS or EMG code \u2014 it is the add-on codes that most practices systematically under-report because charge capture workflows are not configured to prompt for them.<\/p>\r\n

Key add-ons with direct revenue recovery value:<\/p>\r\n